Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Santner Viktoria |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2025
Originalarbeit (Zeitschrift)
** Cejka, V; Riepl, H; Schwegel, N; Kolesnik, E; Zach, D; Santner, V; Höller, V; Schweighofer, N; Obermayer-Pietsch, B; Pieber, T; Morbach, C; Frantz, S; Zirlik, A; von, Lewinski, D; Störk, S; Posch, F; Ablasser, K; Verheyen, N
Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.
ESC Heart Fail. 2025; 12(3):2113-2124
Doi: 10.1002/ehf2.15221
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Strohhofer, C; Kolesnik, E; Oltean, S; Hüttmair, A; Pipp, C; Benedikt, M; Verheyen, N; Gollmer, J; Ablasser, K; Wallner, M; Santner, V; Tripolt, N; Pferschy, P; Zechner, P; Alber, H; Siller-Matula, JM; Kopp, K; Zirlik, A; Aziz, F; Sourij, H; von, Lewinski, D
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Clin Res Cardiol. 2025; 114(5):629-639
Doi: 10.1007/s00392-024-02523-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Höller, V; Santner, V; Schmid, J; Zirlik, A; Verheyen, N
Variant cardiac transthyretin amyloidosis presenting as hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: a case report
EUR HEART J-CASE REP. 2025; 9(2): ytaf029
Doi: 10.1093/ehjcr/ytaf029
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2024
Originalarbeit (Zeitschrift)
** Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19):
Doi: 10.3390/jcm13195966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Zach, D; Peikert, A; Santner, V; Höller, V; Gollmer, J; Späth, J; Riepl, H; Rainer, PP; Wallner, M; Pilz, S; Zirlik, A; von, Lewinski, D; Ablasser, K; Verheyen, N; Kolesnik, E
The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure-A Prospective Study.
J Clin Med. 2024; 13(7): 1930
Doi: 10.3390/jcm13071930
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Schmid, J; Kolesnik, E; Schwegel, N; Späth, J; Kattnig, L; Riepl, H; Zach, D; Santner, V; Höller, V; Pilz, S; Tomaschitz, A; Fuchsjäger, M; Fahrleitner-Pammer, A; Dimai, HP; Obermayer-Pietsch, B; Fruhwald, F; Scherr, D; Zirlik, A; von, Lewinski, D; Ablasser, K
Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
ESC Heart Fail. 2024; 11(3):1730-1738
Doi: 10.1002/ehf2.14741
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zach, DK; Schwegel, N; Santner, V; Winkelbauer, L; Hoeller, V; Kolesnik, E; Gollmer, J; Seggewiss, H; Batzner, A; Perl, S; Wallner, M; Reiter, U; Rainer, PP; Zirlik, A; Ablasser, K; Verheyen, N
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024; 399:131661
Doi: 10.1016/j.ijcard.2023.131661
Web of Science
PubMed
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81
Doi: 10.1016/j.ejim.2023.07.027
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473.
[Poster]
Web of Science
FullText
** Schwegel, N; Riepl, H; Spath, J; Kolesnik, E; Zach, D; Santner, V; Holler, V; Obermayer-Pietsch, B; Schmid, J; Scherr, D; von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N
Role of Comorbidities in Chronic Heart Failure-a prospective cohort study
WIEN KLIN WOCHENSCHR. 2023; 135: S477-S477.
Web of Science
FullText
2022
Abstract (Zeitschrift)
** Santner, V; Riepl, H; Posch, F; Wallner, M; Rainer, P; Ablasser, K; Kolesnik, E; von Lewinski, D; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Eligibility for HFpEF/HFmrEF outcome trials and mortality risk in a cohort of decompensated heart failure patients
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):100-100.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science